April 25, 2017 / 11:36 AM / 3 months ago

BRIEF-Ovid Therapeutics sees IPO of 5 mln shares of common stock - SEC filing

1 Min Read

April 25 (Reuters) - Ovid Therapeutics Inc

* Ovid Therapeutics Inc sees IPO of 5.0 million shares of common stock - SEC filing

* Ovid Therapeutics Inc currently expect the initial public offering price to be between $15.00 and $17.00 per share of common stock

* Ovid Therapeutics says intends to use about $35 million of IPO proceeds to conduct and complete Phase 2 stars trial of OV101 in adults with angelman syndrome

* Ovid Therapeutics says intends to use about $17 million of IPO proceeds to conduct and complete Phase 1B/2A trial of OV935

* Ovid Therapeutics says intends to use about $7 million of IPO proceeds for other ongoing research and development activities related to additional drug candidates Source text: (bit.ly/2q04Gbz)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below